A detailed history of Campion Asset Management transactions in Johnson & Johnson stock. As of the latest transaction made, Campion Asset Management holds 5,448 shares of JNJ stock, worth $895,869. This represents 0.63% of its overall portfolio holdings.

Number of Shares
5,448
Previous 5,483 0.64%
Holding current value
$895,869
Previous $867,000 8.19%
% of portfolio
0.63%
Previous 0.67%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$144.38 - $157.78 $5,053 - $5,522
-35 Reduced 0.64%
5,448 $796,000
Q4 2022

Mar 22, 2023

SELL
$160.2 - $179.79 $52,064 - $58,431
-325 Reduced 5.6%
5,483 $968,000
Q3 2022

Nov 10, 2022

SELL
$161.33 - $179.52 $34,685 - $38,596
-215 Reduced 3.57%
5,808 $949,000
Q2 2021

Jul 23, 2021

SELL
$159.48 - $171.07 $367,601 - $394,316
-2,305 Reduced 27.68%
6,023 $992,000
Q1 2021

Apr 27, 2021

BUY
$153.07 - $170.48 $1.27 Million - $1.42 Million
8,328 New
8,328 $1.37 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $430B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Campion Asset Management Portfolio

Follow Campion Asset Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Campion Asset Management, based on Form 13F filings with the SEC.

News

Stay updated on Campion Asset Management with notifications on news.